BRIDGENE BIOSCIENCES

BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules. It enables covalent small molecules to perform proteome-wide screening in live cells, which results in highly selective small molecules that drug traditionally undruggable targets.

#People #Financial #Website #More

BRIDGENE BIOSCIENCES

Social Links:

Linkedin

Industry:

Biotechnology Therapeutics

Founded:

2018-01-01

Address:

Sunnyvale, California, United States

Country:

United States

Website Url:

http://www.bridgenebio.com

Total Employee:

1+

Status:

Active

Contact:

.(408) 498-8127

Email Addresses:

[email protected]

Total Funding:

50.5 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Font Awesome Mobile Non Scaleable Content Nginx Amazon

Current Employees Featured

ping-cao_image

Ping Cao
Ping Cao Co-Founder and CEO @ BridGene Biosciences
Co-Founder and CEO

Founder

ping-cao_image

Ping Cao

Investors List

dyee-capital_image

Dyee Capital

Dyee Capital investment in Series B - BridGene Biosciences

junson-capital_image

Junson Capital

Junson Capital investment in Series B - BridGene Biosciences

lapam-capital_image

Lapam Capital

Lapam Capital investment in Series B - BridGene Biosciences

kaitai-capital_image

Kaitai Capital

Kaitai Capital investment in Series A - BridGene Biosciences

takeda-ventures_image

Takeda Ventures

Takeda Ventures investment in Series A - BridGene Biosciences

beijing-weidu-capital-management_image

WeDo Capital Management

WeDo Capital Management investment in Series A - BridGene Biosciences

pangu-venture-capital_image

Pangu Venture Capital

Pangu Venture Capital investment in Series A - BridGene Biosciences

Official Site Inspections

http://www.bridgenebio.com

Host Informations
Whois Informations

Loading ...

More informations about "BridGene Biosciences" on Search Engine